Barclays downgrades Array Technologies on weak growth outlook, margin strain
Go back to Barclays downgrades Array Technologies on weak growth outlook, margin strain| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.08 +0.19 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $7.27 | |||
| Open | $4.00 | 52 Week Low | $2.39 | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.94 | EPS | $-0.61 | |||
| Volume | 5,752,718 | |||||
| NYSE Arca Tech 100 ETF (NASDAQ: NXT) | Delayed: 84.30 +4.82 (6.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.48 | 52 Week High | $25.39 | |||
| Open | $82.01 | 52 Week Low | $13.13 | |||
| Day High | $84.89 | P/E | N/A | |||
| Day Low | $81.87 | EPS | $0.00 | |||
| Volume | 2,173,717 | |||||
